- Home
- VYNE vs EQS Comparison
VYNE vs EQS Comparison
Compare VYNE & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- EQS
- Stock Information
- Founded
- VYNE 2003
- EQS 1991
- Country
- VYNE United States
- EQS United States
- Employees
- VYNE N/A
- EQS N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- VYNE Health Care
- EQS Finance
- Exchange
- VYNE Nasdaq
- EQS Nasdaq
- Market Cap
- VYNE 16.0M
- EQS 19.0M
- IPO Year
- VYNE 2018
- EQS N/A
- Fundamental
- Price
- VYNE $1.46
- EQS $1.43
- Analyst Decision
- VYNE Strong Buy
- EQS
- Analyst Count
- VYNE 2
- EQS 0
- Target Price
- VYNE $6.25
- EQS N/A
- AVG Volume (30 Days)
- VYNE 895.6K
- EQS 8.8K
- Earning Date
- VYNE 08-13-2025
- EQS 01-01-0001
- Dividend Yield
- VYNE N/A
- EQS N/A
- EPS Growth
- VYNE N/A
- EQS N/A
- EPS
- VYNE N/A
- EQS N/A
- Revenue
- VYNE $605,000.00
- EQS $1,329,000.00
- Revenue This Year
- VYNE $42.51
- EQS N/A
- Revenue Next Year
- VYNE N/A
- EQS N/A
- P/E Ratio
- VYNE N/A
- EQS N/A
- Revenue Growth
- VYNE 43.03
- EQS 152.66
- 52 Week Low
- VYNE $0.85
- EQS $0.74
- 52 Week High
- VYNE $4.30
- EQS $1.52
- Technical
- Relative Strength Index (RSI)
- VYNE 56.57
- EQS 61.15
- Support Level
- VYNE $1.10
- EQS $1.42
- Resistance Level
- VYNE $1.49
- EQS $1.43
- Average True Range (ATR)
- VYNE 0.15
- EQS 0.02
- MACD
- VYNE -0.00
- EQS -0.01
- Stochastic Oscillator
- VYNE 90.45
- EQS 75.00
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.